4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-20-049425
President sold 25,000 shares at an average $92.62 ($2,315,578)
- President acquired 25,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Novak Rodger President | 2020-09-01 | Option exercise | +3,933 | $14.00 | $55,062 | 651,940 | D |
| Novak Rodger President | 2020-09-01 | Option exercise | +21,067 | $14.43 | $303,997 | 673,007 | D |
| Novak Rodger President | 2020-09-01 | Sale | −1,406 | $91.54 | $128,705 | 671,601 | D |
| Novak Rodger President | 2020-09-01 | Sale | −19,754 | $92.59 | $1,829,023 | 651,847 | D |
| Novak Rodger President | 2020-09-01 | Sale | −3,840 | $93.19 | $357,850 | 648,007 | D |
| Derivatives | |||||||
| Novak Rodger President | 2020-09-01 | Option exercise · Stock Option (Right to Buy) | −3,933 | 111,893 | D | ||
| Novak Rodger President | 2020-09-01 | Option exercise · Stock Option (Right to Buy) | −21,067 | 215,315 | D | ||
| Open-market sales · 25,000 sh · avg $92.62 · $2,315,578 | |||||||
Loading xslF345X03/doc4.xml…